These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30003898)

  • 1. Submicron Size Particles of a Murine Monoclonal Antibody Are More Immunogenic Than Soluble Oligomers or Micron Size Particles Upon Subcutaneous Administration in Mice.
    Kijanka G; Bee JS; Korman SA; Wu Y; Roskos LK; Schenerman MA; Slütter B; Jiskoot W
    J Pharm Sci; 2018 Nov; 107(11):2847-2859. PubMed ID: 30003898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fate of Multimeric Oligomers, Submicron, and Micron Size Aggregates of Monoclonal Antibodies Upon Subcutaneous Injection in Mice.
    Kijanka G; Bee JS; Bishop SM; Que I; Löwik C; Jiskoot W
    J Pharm Sci; 2016 May; 105(5):1693-1704. PubMed ID: 27044942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the immunogenicity of different types of aggregates of a murine monoclonal antibody in mice.
    Freitag AJ; Shomali M; Michalakis S; Biel M; Siedler M; Kaymakcalan Z; Carpenter JF; Randolph TW; Winter G; Engert J
    Pharm Res; 2015 Feb; 32(2):430-44. PubMed ID: 25123991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal Antibody Dimers Induced by Low pH, Heat, or Light Exposure Are Not Immunogenic Upon Subcutaneous Administration in a Mouse Model.
    Kijanka G; Bee JS; Schenerman MA; Korman SA; Wu Y; Slütter B; Jiskoot W
    J Pharm Sci; 2020 Jan; 109(1):730-738. PubMed ID: 31029572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical characterization and in vitro biological impact of highly aggregated antibodies separated into size-enriched populations by fluorescence-activated cell sorting.
    Telikepalli S; Shinogle HE; Thapa PS; Kim JH; Deshpande M; Jawa V; Middaugh CR; Narhi LO; Joubert MK; Volkin DB
    J Pharm Sci; 2015 May; 104(5):1575-91. PubMed ID: 25753756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunogenicity of antibody aggregates in a novel transgenic mouse model.
    Bessa J; Boeckle S; Beck H; Buckel T; Schlicht S; Ebeling M; Kiialainen A; Koulov A; Boll B; Weiser T; Singer T; Rolink AG; Iglesias A
    Pharm Res; 2015 Jul; 32(7):2344-59. PubMed ID: 25630815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Small Oligomeric Protein Aggregates on the Immunogenicity of Intravenous and Subcutaneous Administered Antibodies.
    Fathallah AM; Chiang M; Mishra A; Kumar S; Xue L; Russell Middaugh C; Balu-Iyer SV
    J Pharm Sci; 2015 Nov; 104(11):3691-3702. PubMed ID: 26228094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody responses in mice to particles formed from adsorption of a murine monoclonal antibody onto glass microparticles.
    Shomali M; Freitag A; Engert J; Siedler M; Kaymakcalan Z; Winter G; Carpenter JF; Randolph TW
    J Pharm Sci; 2014 Jan; 103(1):78-89. PubMed ID: 24227137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive Chemical Modifications in the Primary Protein Structure of IgG1 Subvisible Particles Are Necessary for Breaking Immune Tolerance.
    Boll B; Bessa J; Folzer E; Ríos Quiroz A; Schmidt R; Bulau P; Finkler C; Mahler HC; Huwyler J; Iglesias A; Koulov AV
    Mol Pharm; 2017 Apr; 14(4):1292-1299. PubMed ID: 28206769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compatibility, physical stability, and characterization of an IgG4 monoclonal antibody after dilution into different intravenous administration bags.
    Kumru OS; Liu J; Ji JA; Cheng W; Wang YJ; Wang T; Joshi SB; Middaugh CR; Volkin DB
    J Pharm Sci; 2012 Oct; 101(10):3636-50. PubMed ID: 22733600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of protein aggregates of a monoclonal antibody generated by forced shaking stress with siliconized and nonsiliconized syringes in BALB/c mice.
    Uchino T; Miyazaki Y; Yamazaki T; Kagawa Y
    J Pharm Pharmacol; 2017 Oct; 69(10):1341-1351. PubMed ID: 28639328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of a Heat Shock Protein Impurity on the Immunogenicity of Biotherapeutic Monoclonal Antibodies.
    Rane SS; Dearman RJ; Kimber I; Uddin S; Bishop S; Shah M; Podmore A; Pluen A; Derrick JP
    Pharm Res; 2019 Feb; 36(4):51. PubMed ID: 30771015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a dual-wavelength size exclusion HPLC method with improved sensitivity to detect protein aggregates and its use to better characterize degradation pathways of an IgG1 monoclonal antibody.
    Bond MD; Panek ME; Zhang Z; Wang D; Mehndiratta P; Zhao H; Gunton K; Ni A; Nedved ML; Burman S; Volkin DB
    J Pharm Sci; 2010 Jun; 99(6):2582-97. PubMed ID: 20039394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical and Biophysical Characteristics of Monoclonal Antibody Solutions Containing Aggregates Formed during Metal Catalyzed Oxidation.
    Narhi LO; Luo Q; Wypych J; Torosantucci R; Hawe A; Fujimori K; Nashed-Samuel Y; Jawa V; Joubert MK; Jiskoot W
    Pharm Res; 2017 Dec; 34(12):2817-2828. PubMed ID: 29110285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and Sizing of Submicron Particles in Biologics With Interferometric Scattering Microscopy.
    Wong NA; Uchida NV; Dissanayake TU; Patel M; Iqbal M; Woehl TJ
    J Pharm Sci; 2020 Jan; 109(1):881-890. PubMed ID: 31160046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural characterization of IgG1 mAb aggregates and particles generated under various stress conditions.
    Telikepalli SN; Kumru OS; Kalonia C; Esfandiary R; Joshi SB; Middaugh CR; Volkin DB
    J Pharm Sci; 2014 Mar; 103(3):796-809. PubMed ID: 24452866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing Submicron Aggregation Kinetics of an IgG Protein by Asymmetrical Flow Field-Flow Fractionation.
    Bria CR; Jones J; Charlesworth A; Ratanathanawongs Williams SK
    J Pharm Sci; 2016 Jan; 105(1):31-9. PubMed ID: 26579993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the Increased Aggregation Propensity of a Light-Exposed IgG1 Monoclonal Antibody Using Hydrogen Exchange Mass Spectrometry, Biophysical Characterization, and Structural Analysis.
    Bommana R; Chai Q; Schöneich C; Weiss WF; Majumdar R
    J Pharm Sci; 2018 Jun; 107(6):1498-1511. PubMed ID: 29408480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonnative aggregation of an IgG1 antibody in acidic conditions, part 2: nucleation and growth kinetics with competing growth mechanisms.
    Brummitt RK; Nesta DP; Chang L; Kroetsch AM; Roberts CJ
    J Pharm Sci; 2011 Jun; 100(6):2104-19. PubMed ID: 21213307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant murine growth hormone particles are more immunogenic with intravenous than subcutaneous administration.
    Christie M; Torres RM; Kedl RM; Randolph TW; Carpenter JF
    J Pharm Sci; 2014 Jan; 103(1):128-39. PubMed ID: 25133276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.